课题基金 / 基金详情

CONFERENCE ON TYPE 2 CYTOKINES

CONFERENCE ON TYPE 2 CYTOKINES
2 型细胞因子会议
批准号:
2743552
负责人:
FRED Douglass FINKELMAN
金额:
$0.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-02-01 至 2000-01-31

项目摘要

项目成果

FRED Douglass FINKELMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Similar inflammatory, immunologic, and physiologic events characterize both allergy and worm infections. Increased understanding of the roles of specific cytokines in evoking these events has had a major impact on both allergy and parasitology research. Critical issues common to both research fields include understanding how T cell cytokine responses are regulated and how interactions among cytokines, inflammatory cells and inflammatory mediators limit worm infections and produce allergic symptoms. This conference will promote communication among researchers in allergy, asthma and parasitology with the view that ideas, reagents, and techniques that are used to study one field will often benefit studies in the other. Plenary session topics include regulation of cytokine responses by cytokines, antigens, and antigen presenting cells; roles of antibodies, inflammatory cells, inflammatory mediators, and the nervous system in allergy, asthma, and worm expulsion; and cytokine and neural regulation of gastrointestinal and pulmonary physiology, responsiveness and inflammation. Joint plenary sessions will be held with the concurrent asthma meeting on animal models of asthma and immunotherapy of allergy and asthma. Joint workshops will cover the roles of eosinophils, mast cells, and basophils in allergy, asthma, and host defense, animal models of asthma, and novel approaches to therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb
  • 批准号:
    10468082
  • 项目类别:
  • 资助金额:
    $56.61万
  • 财政年份:
    2019
  • 负责人:
    FRED Douglass FINKELMAN
  • 依托单位:
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb
  • 批准号:
    10213608
  • 项目类别:
  • 资助金额:
    $56.61万
  • 财政年份:
    2019
  • 负责人:
    FRED Douglass FINKELMAN
  • 依托单位:
Rapid, safe suppression of IgE-mediated disease with monovalent anti-ceRIa mAb
  • 批准号:
    10645062
  • 项目类别:
  • 资助金额:
    $54.12万
  • 财政年份:
    2019
  • 负责人:
    FRED Douglass FINKELMAN
  • 依托单位:
Wimpy antibody isotypes protect against antibody-mediated disease
  • 批准号:
    9287287
  • 项目类别:
  • 资助金额:
    $37.18万
  • 财政年份:
    2017
  • 负责人:
    FRED Douglass FINKELMAN
  • 依托单位:
海外基金